GlucoBalance®, Dr Vegan, 60s

Glucobalance® Ingredients: Inositol, Apple Cider Vinegar Powder (Malus Sylvestris), Alpha Lipoic Acid, Maitake Mushroom Powder (Grifola Frondosa). Fenugreek Seed Extract (Trigonella Foenum-Graecum), Bitter Melon Extract (Momordica Charantia). Ceylon Cinnamon Bark Extract (Cinnamomum Zeylanicum), Chromium Picolinate, Capsule Shell (Hydroxypropyl Methylcellulose).

Glucobalance® Directions: Take two capsules daily with your main meal of the day.

Study:

This study shows how Inositol may improve blood glucose levels and insulin resistance in difference health conditions. From this study: “Several studies have demonstrated the insulin-sensitizing role of myo-inositol in conditions such as PCOS, post-menopausal metabolic syndrome, type 2 diabetes, and GDM. PCOS is a widely studied syndrome associated with insulin resistance. For which insulin-sensitizing factors have been proposed as putative treatments to improve the hyperinsulinemia-related dysfunction of ovarian response to endogenous gonadotropins. Among the insulin-sensitizing compounds, myo-inositol has shown a beneficial effect on improving insulin sensitivity. Plus, restoring spontaneous ovarian activity, and consequently fertility in PCOS patients.

Post-menopausal metabolic syndrome is another insulin-resistant syndrome with a good response to myo-inositol administration. In fact, it has been demonstrated that myo-inositol may decrease insulin resistance by approximately 70% in post-menopausal women with metabolic syndrome. Another common disorder in which insulin resistance constitutes a crucial factor is type 2 diabetes mellitus (T2DM). T2DM is characterized by an increase in insulin resistance of the target tissues and a deficiency of insulin secretion from the pancreas.

The first-line therapy for T2DM is metformin, an insulin sensitizer drug. However, myo-inositol and D-chiro-inositol have shown a direct beneficial effect on glycemic parameters. This is true in patients with T2DM, such as a significant reduction in blood glucose and HbA1c levels. Furthermore, inositol administration did not lead to any side effect, confirming the safety of this intervention.”